In Memory of Dr. John (Jack) J. Baldwin

image

Bright Science, Clear Vision

iVIEW Therapeutics Inc. is a clinical-stage ophthalmology-focused therapeutics company based in Cranbury, New Jersey committed to the treatment of ocular diseases with high unmet medical needs through innovative small molecule drugs and gene therapy approaches. Our focus on novel mechanisms of action combined with our proprietary drug delivery technology platforms allows us to bring forward highly differentiated assets with potentially superior target product profiles. Currently, our portfolio includes novel products to treat Acute Infectious Conjunctivitis, Dry Eye Disease (DED), Myopia and Glaucoma.

Differentiated Innovative Pipeline

Innovative Pipeline:

Sustainable Innovative Drug Development:

  • TRPM8 Technology
  • Target Based Small Molecule Discovery
  • Gene Therapy Development

NDDS Platform Technology:

Innovative Drug Delivery Technology Platforms:

  • i-Gel In-situ Gel Technology Platform
  • Nano-micelle Technology Platform

Target Unmet Medical Needs:

Disease Areas for Significant Unmet Medical Need:

  • Dry Eye
  • Myopia
  • Viral Conjunctivitis
  • Glaucoma Treatment
Image cant be loaded

CUTTING-EDGE
TECHNOLOGY

TRPM8 Agonist
Technology

LATEST UPDATES

In Memory of Dr. John (Jack) J. Baldwin

IVIEW Therapeutics to Present Cutting-Edge Ocular Research at ARVO 2025 in Salt Lake City

Copyright © 2025 iVIEW Therapeutics, Inc. All rights reserved.

Terms of Use

Privacy Policy